Abstract:Shigella invasion plasmid antigen B (IpaB) plays an important role in causing shigellosis. While IpaB's protein structure, contribution to disease mechanism, and protective immunity against Shigella infection have been well studied, the significance of individual antigenic domains, especially at the N terminus, has not been systematically characterized. In an attempt to identify IpaB protein functional epitopes and to construct an optimized polyvalent multiepitope fusion antigen (MEFA) immunogen for development of a protein-based cross protective Shigella vaccine, in this study, we in silico identified immunodominant B-cell epitopes from the IpaB N terminus, fused each epitope to carrier protein CsaB (the major subunit of enterotoxigenic Escherichia coli CS4 adhesin) for epitope fusion proteins, immunized mice with each epitope fusion protein, examined IpaB-specific antibody responses, and assessed antibody functional activity against Shigella bacterial invasion. A total of 10 B-cell continuous epitopes were identified from IpaB N terminus, and after being fused to carrier protein CsaB, each epitope induced anti-IpaB IgG responses in the intramuscularly immunized mice. While in vitro antibody invasion inhibition assays demonstrated that antibodies derived from each identified epitope were functional, epitopes 1 (LAKILASTELGDNTIQAA), 2 (HSTSNILIPELKAPKSL), and 4 (QARQQKNLEFSDKI) induced antibodies to inhibit Shigella sonnei and Shigella flexneri invasion at levels similar to those of recombinant IpaB protein, suggesting that these three IpaB epitopes can be used potentially as IpaB-representing antigens to induce protective anti-IpaB antibodies and for construction of an epitope-based polyvalent MEFA protein immunogen for Shigella vaccine development. IMPORTANCE Currently, there are no effective measures for control or prevention of Shigella infection, the most common cause of diarrhea in children 3 to 5 years of age in developing countries. Challenges in developing Shigella vaccines include virulence heterogeneity among species and serotypes. To overcome virulence heterogeneity challenge and to develop a protein-based multivalent Shigella vaccine, we targeted a panel of virulence factors, including invasion plasmid antigens, identified functional antigenic domains or epitopes as representative antigens, and applied the novel epitope- and structure-based vaccinology platform multiepitope fusion antigen (MEFA) to integrate functional antigenic domains or epitopes into a backbone immunogen to produce a polyvalent immunogen for cross protective antibodies. Identification of functional IpaB epitopes from this study enhances our understanding of IpaB immunogenicity and allows us to directly utilize IpaB epitopes for construction of a cross protective polyvalent Shigella immunogen and to accelerate development of a protein-based Shigella vaccine. Currently, there are no effective measures for control or prevention of Shigella infection, the most common cause of diarrhea in children 3 to 5 years of age in developing countries. Challenges in developing Shigella vaccines include virulence heterogeneity among species and serotypes.

Design Synthesis and Immunological Reaction of Epitope Peptides of ETEC K88 and K99 Fimbrial Protein

Mapping the neutralizing epitopes of enterotoxigenic (ETEC) K88 (F4) fimbrial adhesin and major subunit FaeG.

Identifying Immuno-Dominant and Neutralizing Epitopes from K88 Fimbriae of Enterotoxigenic Escherichia coli (ETEC)

Expression of T and B cells combined epitopes protein of Leptospira interrogans and the immunity analysis

Antigen Epitope Peptides and Immunogenicity Analysis of E.coli O157∶H7 Ivy Protein

Immunoinformatics and molecular dynamics studies to predict T-cell-specific epitopes of four Klebsiella pneumoniae fimbriae antigens

Characterization of the Binding Specificity of K88ac and K88ad Fimbriae of Enterotoxigenic Escherichia Coli by Constructing K88ac/K88ad Chimeric FaeG Major Subunits

Clone and expression of pili subunit gene from the pathogenic factor adhesion F41 and K99 of the Enterotoxigenic Escherichia coli(ETEC)

Antigen Epitopes Analysis and Verification of Escherichia coli O157 : H7 Flagellin

Detecting the Dominant T and B Epitopes of Klebsiella pneumoniae Ferric Enterobactin Protein (FepA) and Introducing a Single Epitopic Peptide as Vaccine Candidate

[Prediction and Immunologic Identification of Antigenic Epitopes in Genus-Specific Outer Membrane Protein LipL41 of Leptospira Interrogans].

Targeting Peptide‐enhanced Antibody and CD11c+ Dendritic Cells to Inclusion Bodies Expressing Protective Antigen Against ETEC in Mice

Characterization of Functional B-Cell Epitopes at the Amino Terminus of Shigella Invasion Plasmid Antigen B (IpaB)

INDUCTION OF IMMUNE RESPONSES IN MICE AFTER ORAL IMMUNIZATION WITH RECOMBINANT LACTOBACILLUS CASEI STRAINS EXPRESSING ENTEROTOXIGENICESCHERICHIA COLI F41 FIMBRIAL PROTEIN

Development of an indirect ELISA for detecting antibodies to adhesins of ETEC

Immunogenicity and Protective Efficacy of Orally or Intranasally Administered Recombinant Lactobacillus Casei Expressing ETEC K99

Immunization with Recombinant Lactobacillus Casei Strains Producing K99, K88 Fimbrial Protein Protects Mice Against Enterotoxigenic Escherichia Coli.

Prediction, Recombination and Expression of the Antigenic Spitopes in Autolysin LytA of Streptococcus Pneumoniae

Expression of Fusion Protein Stx2B-Tir-Stx1B from Enterohemorrhagic Escherichia Coli O157: H7 and Its Immunogenicity Analysis in BALB/c Mice

Epitope-Directed Antibody Elicitation by Genetically Encoded Chemical Cross-Linking Reactivity in the Antigen

Secretory Expression of K88 (F4) Fimbrial Adhesin FaeG by Recombinant Lactococcus Lactis for Oral Vaccination and Its Protective Immune Response in Mice.